The company is not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale by the selling stockholders of such shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSNL:
- Personalis reports Q4 EPS (23c), consensus (28c)
- Personalis sees Q1 revenue $17M-$18M, consensus $16.25M
- Personalis sees FY25 revenue $80M-$90M, consensus $84.65M
- Personalis price target lowered to $8 from $11 at H.C. Wainwright
- Personalis publishes results from TRACERx lung cancer study in Nature Medicine